Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies

Molecular Biology of the Cell

Volumn 13, Issue 2, 2002, Pages 723-737

  Blanpain, Cédric ^a   Vanderwinden, Jean Marie ^a   Cihak, Josef ^a   Wittamer, Valérie ^a   Le Poul, Emmanuel ^a   Issafras, Hassan ^a   Stangassinger, Manfred ^a   Vassart, Gilbert ^a   Marullo, Stefano ^a   Schlöndorff, Detlef ^a   Parmentier, Marc ^a   Mack, Matthias ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; EPITOPE; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MC 1; MONOCLONAL ANTIBODY MC 4; MONOCLONAL ANTIBODY MC 5; MONOCLONAL ANTIBODY MC 6; MONOCLONAL ANTIBODY MC 7; OLIGOMER; RANTES; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; MOLECULAR RECOGNITION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING SITES; CRICETINAE; ENDOCYTOSIS; HIV-1; HUMANS; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036178934     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.01-03-0129     Document Type: Article

References (64)

1. A.T1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
2. Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization
3. H.IV-1 coreceptor activity of C.C.R5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
4. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor C.X.C.R4 contributes to inhibition of HIV replication
5. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (B.R.E.T)
6. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
7. Chemokines and leukocyte traffic
8. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5′4432
9. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence
10. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
11. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein
12. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
13. Multiple nonfunctional alleles of CCR5 are frequent in various human populations
14. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways
15. Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor
16. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T. cells
17. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
18. Characterization of the C.C.R2 chemokine receptor: Functional CCR2 receptor expression in B cells
19. Chemokines and disease
20. Signaling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: A comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPγS binding induced by IL-8 and GROα
21. Structural and functional aspects of G. protein-coupled receptor oligomerization
22. The amino terminus of human C.C.R5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins
23. Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction
24. Oligomerization of opioid receptors with β2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
25. Morphine activates opioid receptors without causing their rapid internalization
26. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer
27. Epitope mapping of C.C.R5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
28. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization
29. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
30. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro
31. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection
32. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity
33. Ammooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
34. Membranes raft microdomains mediate lateral assemblies required for HIV-1 infection
35. Membrane raft microdomains mediate front-rear polarity in migrating cells
36. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy
37. Chemokine control of HIV-1 infection
38. Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features
39. New Targets for inhibitor of HIV-1 replication
40. Nomenclature for chemokine receptors
41. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
42. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
43. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
44. G-protein-coupled receptors function as oligomers in vivo
45. A receptor-G protein coupling-independent step in the internalization of the thyrotropin-releasing hormone receptor
46. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
47. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
48. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: Implications for chemotaxis
49. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor
50. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
51. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
52. The second extracellular loop of CCR5 is the major determinant of ligand specificity
53. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
54. Leukocyte polarization in cell migration and immune interactions
55. Endocytosis and recycling of the HIV coreceptor CCR5
56. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
57. Agonistinduced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state
58. Antibody to epitope tag induces internalization of human muscarinic subtype 1 receptor
59. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
60. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
61. G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition
62. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
63. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
64. Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis